SUN Pharmaceutical Industries Limited Lenalidomide Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Lenalidomide Export Records India — #1 Exporter, 144 Shipments, $7.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

SUN Pharmaceutical Industries Limited — Lenalidomide Exporter #1 | $7.2M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Lenalidomide Exporter Profile

Indian Pharmaceutical Exporter · #1 for Lenalidomide · $7.2M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Lenalidomide with $7.2M in export value and 144 verified shipments. SUN Pharmaceutical Industries Limited holds a 5.3% market share in Lenalidomide exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Lenalidomide Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Lenalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Lenalidomide?

Country	Value	Shipments	Share
BELGIUM	$1.7M	88	49.7%
UNITED STATES	$1.3M	25	36.0%
CANADA	$450.0K	9	13.0%
PHILIPPINES	$47.6K	2	1.4%

Who Are the Top Buyers of Lenalidomide from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$1.7M	79
SUN PHARMACEUTICAL INDUSTRIESINC.	UNITED STATES	$400.0K	8
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$350.0K	7
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$350.0K	7
TARO PHARMACEUTICALS INC.,	CANADA	$150.0K	3
TARO PHARMACEUTICALS INC.	CANADA	$150.0K	3
TARO PHARMACEUTICALS INC	CANADA	$100.0K	2
SUN PHARMACEUTICAL INDUSTRIES,INC..	UNITED STATES	$100.0K	2
2 INDEPENDENCE WAY PRINCETON NJ	UNITED STATES	$50.0K	1
M/S TARO PHARMACEUTICALS INC.,	CANADA	$50.0K	1

SUN Pharmaceutical Industries Limited supplies Lenalidomide to 15 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMACEUTICAL INDUSTRIESINC. (UNITED STATES) and SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lenalidomide Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
LENALIDOMIDE CAPSULES 5MG [8961 PACK X 3X7'S]NOS	$137.1K	3
LENALIDOMIDE CAPS 10MG 3X7'S UK PACK : 3	$122.0K	5
LENALIDOMIDE CAPS 10MG 3X7'S GERMANY PAC	$100.0K	2
LENALIDOMIDE CAPSULES 10 MG 28C USA (PACK : 28 CAPSULE)	$100.0K	2
LENALIDOMIDE CAPSULES 15 MG 21C USA (PACK : 21 CAPSULE)	$100.0K	2
LENALIDOMIDE CAPSULES 20 MG (ACT. QTY. 1032PACK X 21CAPSULE)NOS	$100.0K	2
TARO-LENALIDOMIDE CAPSULES 10MG (342 PACK X 4X7) (BATCH NO. HAF2787C MFG DT. 11/2024 EXP DT. 10/2026)	$100.0K	2
LENALIDOMIDE CAPS 25MG 3X7'S UK PACK : 3	$99.0K	2
LENALIDOMIDE CAPS 20MG 3X7'S GERMANY PAC	$82.3K	2
LENALIDOMIDE CAPS 7.5MG 3X7'S GERMANY PA	$50.0K	1

SUN Pharmaceutical Industries Limited exports 124 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LENALIDOMIDE CAPSULES 5MG [8961 PACK X 3X7'S]NOS with 3 shipments worth $137.1K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Lenalidomide Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	EUGIA PHARMA SPECIALITIES LIMITED	$9.4M	189	3	$50.0K
5	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$8.3M	281	16	$29.4K
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$7.2M	144	6	$50.0K
4	CIPLA LIMITED	$2.1M	42	6	$50.0K
6	HETERO LABS LIMITED	$1.1M	23	8	$50.0K

SUN Pharmaceutical Industries Limited ranks #1 among 237 Indian Lenalidomide exporters. Average shipment value of $50.0K compared to the market average of $128.1K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Lenalidomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	740	27.2%
SAHAR AIR	688	25.3%
DELHI AIR CARGO ACC (INDEL4)	187	6.9%
Bombay Air	180	6.6%
DELHI AIR	140	5.1%
Bombay Air Cargo	88	3.2%
HYDERABAD ACC (INHYD4)	78	2.9%
HYDERABAD AIR	68	2.5%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Lenalidomide Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 144 individual customs records matching SUN Pharmaceutical Industries Limited exporting Lenalidomide, covering 124 formulations to 6 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 557+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lenalidomide

Lenalidomide

SUN Pharmaceutical Industries Limited — Lenalidomide Exporter Profile

SUN Pharmaceutical Industries Limited — Lenalidomide Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Lenalidomide?

Who Are the Top Buyers of Lenalidomide from SUN Pharmaceutical Industries Limited?

What Is India's Total Lenalidomide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Lenalidomide Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Lenalidomide Exporters?

What Lenalidomide Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Lenalidomide to Key Markets

United States — FDA

Canada — HC

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Lenalidomide Exporters?

Which Indian Ports Ship Lenalidomide Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Lenalidomide Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lenalidomide Export Data from SUN Pharmaceutical Industries Limited

Lenalidomide Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source